(Q43669793)

25 November 2017

title

Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients (English)

1 reference

25 November 2017

1 reference

Suncica Buljevic

1

1 reference

25 November 2017

Dijana Detel

2

1 reference

25 November 2017

Lara Baticic Pucar

3

1 reference

25 November 2017

Radovan Mihelic

4

1 reference

25 November 2017

Tomislav Madarevic

5

1 reference

25 November 2017

Branko Sestan

6

1 reference

25 November 2017

Jadranka Varljen

7

1 reference

25 November 2017

publication date

18 July 2013

1 reference

Rheumatology International

25 November 2017

published in

1 reference

25 November 2017

volume

33

1 reference

25 November 2017

issue

11

1 reference

25 November 2017

page(s)

2867-2874

1 reference

https://scigraph.springernature.com/pub.10.1007/s00296-013-2823-z

25 November 2017

exact match

0 references

cites work

CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes.

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

'Dipeptidyl peptidase-IV activity and/or structure homologs' (DASH) in growth-modulated glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Dipeptidyl-peptidase IV (CD26)--role in the inactivation of regulatory peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Dipeptidyl peptidase IV activity and/or structure homologs: contributing factors in the pathogenesis of rheumatoid arthritis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Molecular aspects of rheumatoid arthritis: chemokines in the joints of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Diffuse endocrine system, neuroendocrine tumors and immunity: what's new?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Kinetic study of neuropeptide Y (NPY) proteolysis in blood and identification of NPY3-35: a new peptide generated by plasma kallikrein

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

NPY and receptors in immune and inflammatory diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

The significance of vasoactive intestinal peptide in immunomodulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Signaling mechanisms of vasoactive intestinal peptide in inflammatory conditions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Increase of sympathetic outflow measured by neuropeptide Y and decrease of the hypothalamic-pituitary-adrenal axis tone in patients with systemic lupus erythematosus and rheumatoid arthritis: another example of uncoupling of response systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

More sympathy for autoimmunity with neuropeptide Y?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Substance P-, calcitonin gene-related peptide-and C-flanking peptide of neuropeptide Y-immunoreactive fibres are present in normal synovium but depleted in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Vasoactive intestinal peptide modulates proinflammatory mediator synthesis in osteoarthritic and rheumatoid synovial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

EULAR evidence-based recommendations for the diagnosis of knee osteoarthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Pathophysiology of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Neuroimmune interactions in stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Neuropeptides as pleiotropic modulators of the immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Circulating CD26 is negatively associated with inflammation in human and experimental arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Dipeptidyl peptidase-IV in synovial fluid and in synovial fluid mononuclear cells of patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Serum interleukin-12, interleukin-15, soluble CD26, and adenosine deaminase in patients with rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Neuroimmunomodulative properties of dipeptidyl peptidase IV/CD26 in a TNBS-induced model of colitis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Dipeptidyl peptidase-4 (CD26): knowing the function before inhibiting the enzyme

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Relevance of neuropeptide Y for the neuroimmune crosstalk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Molecular mechanisms regulating Th1 immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

21 January 2018

Neuropeptide Y (NPY).

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

A fundamental bimodal role for neuropeptide Y1 receptor in the immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Neuropeptide Y (NPY) suppresses experimental autoimmune encephalomyelitis: NPY1 receptor-specific inhibition of autoreactive Th1 responses in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Vasoactive intestinal peptide in the immune system: potential therapeutic role in inflammatory and autoimmune diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Therapeutic effects of vasoactive intestinal peptide in the trinitrobenzene sulfonic acid mice model of Crohn's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

The in vivo expression of dipeptidyl peptidases 8 and 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00296-013-2823-Z

The therapeutic effect of vasoactive intestinal peptide on experimental arthritis is associated with CD4+CD25+ T regulatory cells

21 January 2018

1 reference

12 December 2020

Immunoregulatory properties of vasoactive intestinal peptide in human T cell subsets: implications for rheumatoid arthritis

1 reference

12 December 2020

Expression and functional role of 1F7 (CD26) antigen on peripheral blood and synovial fluid T cells in rheumatoid arthritis patients

1 reference

12 December 2020

Dipeptidyl peptidase IV in patients with systemic lupus erythematosus

1 reference

12 December 2020

Concentration of substance P, neurokinin A, calcitonin gene-related peptide, neuropeptide Y and vasoactive intestinal polypeptide in synovial fluid from knee joints in patients suffering from rheumatoid arthritis

1 reference

12 December 2020

Vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activation polypeptide (PACAP) protect mice from lethal endotoxemia through the inhibition of TNF-alpha and IL-6.

1 reference

12 December 2020

Shift toward T lymphocytes with a T helper 1 cytokine-secretion profile in the joints of patients with rheumatoid arthritis

1 reference

12 December 2020

Characterization of human serum dipeptidyl peptidase IV (CD26) and analysis of its autoantibodies in patients with rheumatoid arthritis and other autoimmune diseases

1 reference

12 December 2020

Vasoactive intestinal peptide prevents experimental arthritis by downregulating both autoimmune and inflammatory components of the disease

1 reference

12 December 2020

Cell surface characterization of T lymphocytes and allergen-specific T cell clones: correlation of CD26 expression with T(H1) subsets

1 reference

12 December 2020

Activities of dipeptidyl peptidase II and dipeptidyl peptidase IV in mice with lupus erythematosus-like syndrome and in patients with lupus erythematosus and rheumatoid arthritis

1 reference

12 December 2020

Identification of the 110000 Mr glycoprotein isolated from rat liver plasma membrane as dipeptidylaminopeptidase IV

1 reference

12 December 2020

10.1007/S00296-013-2823-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

25 November 2017

1046551283

0 references

1 reference